Searchable Title

Smoking Abstinence Self-efficacy Questionnaire (SASEQ) (appears in: Development of a Smoking Abstinence Self-Efficacy Questionnaire.) Copyright: Spek, V.; Lemmens, F.; Chatrou, M.; van Kempen, S.; Pouwer, F.; Pop, V.

Reference Type

Journal Article

Authors, Section

Spek, V.; Lemmens, F.; Chatrou, M.; van Kempen, S.; Pouwer, F.; Pop, V.

Title, Section

Smoking Abstinence Self-efficacy Questionnaire (SASEQ) (appears in: Development of a Smoking Abstinence Self-Efficacy Questionnaire.) Copyright: Spek, V.; Lemmens, F.; Chatrou, M.; van Kempen, S.; Pouwer, F.; Pop, V.

Publication Year

2013

Journal Title

International Journal of Behavioral Medicine

Volume

20

Issue

3

Pages

444-9

Availability

online

PMID

PMID: 22350635

DOI

10.1007/s12529-012-9229-2

Abstract

BACKGROUND: Self-efficacy beliefs are an important determinant of (changes in) health behaviors. In the area of smoking cessation, there is a need for a short, feasible, and validated questionnaire measuring self-efficacy beliefs regarding smoking cessation. PURPOSE: The purpose of this study is to investigate the psychometric properties of a six-item questionnaire to assess smoking cessation self-efficacy. METHODS: We used longitudinal data from a smoking cessation study. A total of 513 smokers completed the Smoking Abstinence Self-efficacy Questionnaire (SASEQ) and questionnaires assessing depressive symptoms and motivation to quit smoking. After that, they set a quit date and attempted to stop smoking. One year after the quit date, smoking status of participants was assessed by self report. The psychometric properties of the SASEQ were studied and we investigated whether SASEQ scores predicted successful smoking cessation. RESULTS: Factor analysis yielded one factor, with an Eigenvalue of 3.83, explaining 64% of variance. All factor loadings were ≥0.73. We found a Cronbach's alpha of 0.89 for the SASEQ, low correlations for the SASEQ with depressive symptoms, and motivation to quit, indicating that self-efficacy is measured independently of these concepts. Furthermore, high baseline SASEQ scores significantly predicted smoking abstinence at 52 weeks after the quit date (OR = 1.85; 95% CI = 1.20~2.84). CONCLUSIONS: The SASEQ appeared to be a short, reliable, and valid questionnaire to assess self-efficacy beliefs regarding smoking abstinence. In the present study, this instrument also had good predictive validity. The short SASEQ can easily be used in busy clinical practice to guide smoking cessation interventions.

Share

COinS